Related Experiment Video
Updated: Feb 20, 2026

High-throughput Screening of Chemical Compounds to Elucidate Their Effects on Bacterial Persistence
Published on: February 23, 2021
High Dose Ofloxacin-induced Bimodal Hallucinations in a 4 Years Old Child
Arnab Bhattacharya1, Rajiv Sharan2, Samir Kumar Praharaj3
1Department of Psychiatry, Tata Motors Hospital, Jamshedpur, India.
Abstract:
Ofloxacin is a commonly used quinolone antibiotic both in adults as well as children. It is generally safe and well tolerated. Rarely, neurological and psychiatric adverse reactions are reported to occur with ofloxacin. We report a case of a child who developed delirium after ofloxacin treatment, that resolved after medication discontinuation and treatment with low dose olanzapine.
Insights
Ofloxacin, a common antibiotic, can rarely cause neurological side effects in children. This case highlights a child
Area of Science:
- Pediatric Pharmacology
- Neuropsychiatry
- Infectious Diseases
Background:
- Ofloxacin is a widely prescribed fluoroquinolone antibiotic for pediatric infections.
- While generally safe, rare adverse drug reactions affecting the central nervous system are documented.
Observation:
- A pediatric patient developed acute delirium.
- The delirium onset was temporally associated with the initiation of ofloxacin therapy.
Findings:
- Discontinuation of ofloxacin led to the resolution of delirium.
- Subsequent low-dose olanzapine treatment was effective in managing residual symptoms.
Implications:
- This case underscores the potential for ofloxacin-induced neuropsychiatric adverse events in children.
- Clinicians should maintain a high index of suspicion for such reactions and consider alternative treatments or careful monitoring.
- Low-dose olanzapine may be a viable option for managing ofloxacin-induced delirium in pediatric patients.
Related Concept Videos
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Toxicity: Dose-Dependent Reactions
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Drug toxicity: Idiosyncratic Reactions
Pharmacokinetics in Pediatric Patients: Drug Metabolism

